Virginia is home to a thriving biopharmaceutical sector, known for its innovative approaches to healthcare. Companies in this field mainly focus on drug discovery, clinical trials, and regulatory consulting, offering vital products and services to enhance patient outcomes. The industry is increasingly moving toward personalized medicine and advanced therapies, driven by technological advancements and evolving patient needs. Virginia's combination of research institutions, skilled workforce, and supportive policy environment contributes to this growth. Interesting to note is the state's strategic partnerships with global organizations, positioning it as a key player in the biopharmaceutical landscape.

The companies listed here range from small biotechnology firms to established consulting organizations, primarily based in Charlottesville and the Northern Virginia area. Many were founded in the last two decades, emphasizing specialties such as drug development, clinical trials, and regulatory guidance. While most are privately owned, they collectively showcase a strong commitment to addressing significant medical challenges, particularly in conditions like diabetes, hormonal health, and rare diseases. With sizes varying between 1 and 500 employees, these companies reflect a rich tapestry of expertise and innovation in the field.

Continue reading to explore the top biopharmaceutical companies in Virginia.

Top 24 Biopharmaceutical Companies Companies in Virginia

1. HemoShear Therapeutics

• Website: hemoshear.com
• Ownership type: Private Equity
• Headquarters: Charlottesville, Virginia, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Other (Debt), $3.5M, November 2023
• Founded year: 2008
• Headcount: 11-50
• LinkedIn: hemoshear-llc

HemoShear Therapeutics, Inc. is a biotechnology company based in Charlottesville, Virginia, founded in 2008. The company specializes in drug discovery and development, particularly targeting rare diseases and metabolic disorders. Utilizing their proprietary REVEAL-Tx platform, HemoShear creates biologically relevant human disease models that help in identifying novel therapeutic candidates. Their primary clientele includes pharmaceutical companies seeking innovative solutions for significant unmet medical needs. HemoShear has formed strategic partnerships with major players in the industry, such as Takeda and Horizon Therapeutics, to advance drug discovery programs. Recently, in November 2023, the company secured $3.5 million in funding, underscoring its active role in the biopharmaceutical landscape and its commitment to developing treatments for conditions like gout and nonalcoholic steatohepatitis (NASH).

2. Biologics Consulting

• Website: biologicsconsulting.com
• Ownership type: Private
• Headquarters: Alexandria, Virginia, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 1993
• Headcount: 51-200
• LinkedIn: biologics-consulting-group

Biologics Consulting, founded in 1993 and based in Alexandria, Virginia, is a consulting firm that provides regulatory and product development services tailored for the biotechnology, pharmaceuticals, and medical devices industries. With a team of experts, including former FDA officials, the company assists clients in navigating the intricate regulatory landscape to successfully bring innovative and safe products to market. They have managed over 4,700 projects and have helped market products in more than 58 countries. Their services cover a wide range of needs, from nonclinical and clinical development to regulatory affairs, making them a valuable partner for companies at various stages of product development. Biologics Consulting prides itself on its collaborative approach, integrating seamlessly with client teams to enhance their regulatory strategies and outcomes.

3. Rivus Pharmaceuticals

• Website: rivuspharma.com
• Ownership type: Venture Capital
• Headquarters: Charlottesville, Virginia, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Series B, $132.0M, September 2022
• Founded year: 2019
• Headcount: 11-50
• LinkedIn: rivus-pharmaceuticals

Rivus Pharmaceuticals, Inc. is a biopharmaceutical company based in Charlottesville, Virginia, founded in 2019. The company is dedicated to enhancing cardiometabolic health through the development of a new class of investigational medicines known as controlled metabolic accelerators (CMAs). These oral small molecules aim to address conditions such as obesity, type 2 diabetes, and heart failure by leveraging the natural process of mitochondrial uncoupling. Rivus' lead candidate, HU6, is currently in clinical development and has demonstrated efficacy in reducing liver fat and improving key metabolic markers in patients. The company has also expanded its pipeline with additional CMA candidates targeting significant unmet medical needs. Rivus has attracted considerable investment, securing $132 million in a Series B funding round in September 2022, which supports its ongoing research and development efforts in the cardiometabolic health space.

4. Adovate

• Website: adovate.com
• Ownership type: Private
• Headquarters: Charlottesville, Virginia, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2019
• Headcount: 11-50
• LinkedIn: adovate

Adovate is a private pharmaceutical company based in Charlottesville, Virginia, founded in 2019. The company specializes in the development of innovative drugs that target adenosine receptors, which are implicated in a range of significant diseases. Utilizing a proprietary drug development platform, Adovate aims to create effective drug candidates that overcome historical challenges related to drug efficacy and delivery. Their approach involves designing patentable compounds with favorable physiochemical properties, which enhances their potential for success in the competitive pharmaceutical market. Adovate's primary customers include healthcare providers and other pharmaceutical companies seeking advanced treatment solutions. The company has not reported any funding to date, indicating a self-sustained approach to its operations and development efforts.

5. PBM Capital Group

• Website: pbmcap.com
• Ownership type: Private
• Headquarters: Charlottesville, Virginia, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2010
• Headcount: 11-50
• LinkedIn: pbm-capital-group

PBM Capital Group, founded in 2010 and based in Charlottesville, Virginia, is a private investment firm dedicated to the healthcare sector. The firm specializes in partnering with scientists and entrepreneurs to develop innovative pharmaceutical products. PBM Capital provides not only funding but also operational management to its portfolio companies, which primarily operate within the pharmaceutical and life sciences industries. The firm has a track record of creating significant shareholder value, with its portfolio companies generating over $10 billion since its inception. Notable companies in its portfolio include Verrica Pharmaceuticals, which focuses on skin diseases, and Dova Pharmaceuticals, which addresses rare diseases. PBM Capital's approach combines extensive industry knowledge with strategic relationships, enabling its partners to navigate the complexities of bringing life-changing therapies to market.

6. Sofie

• Website: sofie.com
• Ownership type: Private Equity
• Headquarters: Dulles, Virginia, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: January 2024
• Founded year: 2008
• Headcount: 201-500
• LinkedIn: sofiebio

Sofie Biosciences, founded in 2008 and based in Dulles, Virginia, is a private equity-backed healthcare and pharmaceutical company. It specializes in the development and delivery of radiopharmaceuticals and molecular diagnostics. Sofie is known for its innovative PET tracers and theranostic agents, which are designed to enhance diagnostic accuracy and improve patient outcomes. The company operates a network of radiopharmacies and offers contract manufacturing services, ensuring a reliable supply of its products. Sofie's pipeline includes promising compounds like [68Ga]FAPI-46 and [18F]FAPI-74, which are currently in Phase 2 clinical trials for various cancer indications. Their strategic partnerships, such as the recent licensing agreement with GE HealthCare, further solidify their position in the industry, showcasing their commitment to advancing molecular imaging and theranostics.

7. AMPEL BioSolutions

• Website: ampelbiosolutions.com
• Ownership type: Venture Capital
• Headquarters: Charlottesville, Virginia, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Other (Debt), $1.8M, July 2023
• Founded year: 2013
• Headcount: 11-50
• LinkedIn: ampelbiosolutionsllc

AMPEL BioSolutions, founded in 2013 and based in Charlottesville, Virginia, is a biotechnology firm dedicated to advancing personalized precision medicine through genomic analytics. The company specializes in developing genomic tests aimed at managing autoimmune and inflammatory diseases, catering to both healthcare providers and pharmaceutical companies. Their flagship products, including LuGENE, a blood test for lupus, and CovGENE, which predicts COVID-19 severity, leverage RNA analytics and machine learning to enhance treatment strategies. AMPEL has received significant funding, with a recent debt financing round of $1.8 million in July 2023, underscoring its active role in the biopharmaceutical industry. The company has also been recognized for its innovative contributions, including being named Virginia's Innovator-of-the-Year in 2023. AMPEL's research and product development efforts are focused on various conditions, including lupus, dermatological disorders, nephrology, cardiology, and fibromyalgia, positioning it as a relevant player in the biopharmaceutical field.

8. National Clinical Research, Inc.

• Website: ncrinc.net
• Ownership type: Private
• Headquarters: Richmond, Virginia, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 1995
• Headcount: 11-50
• LinkedIn: national-clinical-research-inc-

National Clinical Research, Inc. (NCR), founded in 1995 and based in Richmond, Virginia, is a clinical research organization dedicated to conducting trials for new medications developed by pharmaceutical companies. With a team of approximately 30 employees, NCR focuses on critical health issues such as obesity, migraines, and Alzheimer's disease. The organization provides patients with opportunities to participate in studies that may lead to new treatment options. NCR's founder, Dr. James M. McKenney, has extensive experience in clinical research, having conducted over 1,000 clinical trials and published numerous scientific articles. The company operates with a commitment to advancing medical knowledge and improving patient care through rigorous research practices. NCR collaborates closely with major pharmaceutical companies, ensuring that their clinical trials meet the necessary regulatory standards and contribute valuable data to the development of new therapies.

9. Zephyr AI

• Website: zephyrai.bio
• Ownership type: Venture Capital
• Headquarters: Tysons, Virginia, United States (USA)
• Latest funding: Series A, $111.0M, March 2024
• Founded year: 2020
• Headcount: 11-50
• LinkedIn: zephyr-ai

Zephyr AI, founded in 2020 and based in Tysons, Virginia, is a healthcare technology company that specializes in precision medicine and artificial intelligence. The company has developed an AI-enabled platform designed to enhance patient outcomes through advanced patient stratification and drug response prediction. Their technology integrates clinical and molecular data to provide actionable insights for healthcare providers and pharmaceutical professionals. This capability is particularly valuable in optimizing clinical trials and streamlining drug development processes. Zephyr AI has garnered attention in the industry, evidenced by their recent Series A funding round, which raised $111 million in March 2024. This funding will likely support their ongoing efforts to innovate and expand their offerings in the biopharmaceutical space.

10. Aclairo Pharmaceutical Development Group

• Website: aclairo.com
• Ownership type: Corporate
• Headquarters: Sterling, Virginia, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: January 2016
• Founded year: 2004
• Headcount: 11-50
• LinkedIn: aclairo-pharmaceutical-development-group-inc.

Aclairo Pharmaceutical Development Group, Inc. is a consulting firm based in Sterling, Virginia, founded in 2004. The company specializes in pharmaceutical development, offering a range of services that include regulatory guidance, scientific writing, and strategic consulting. Aclairo's team consists of experienced professionals, many of whom have backgrounds as FDA supervisors and reviewers. This expertise allows them to assist clients in navigating the complexities of drug development and regulatory compliance. They provide tailored support for various stages of pharmaceutical development, including preclinical study planning, clinical pharmacology, and regulatory submissions. Aclairo has successfully contributed to numerous IND and NDA submissions, showcasing their capability in facilitating the drug approval process. Their commitment to high-quality consultation and support has made them a trusted partner for pharmaceutical companies looking to advance their products through the regulatory maze.

11. Health Research of Hampton Roads, Inc.

• Website: hrhr-inc.com
• Ownership type: Private
• Headquarters: Newport News, Virginia, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2000
• Headcount: 11-50
• LinkedIn: health-research-of-hampton-roads-inc-

Health Research of Hampton Roads, Inc. (HRHR) is a private clinical research organization based in Newport News, Virginia, established in 2000. The company specializes in conducting FDA-regulated clinical trials for pharmaceutical and biotech firms, focusing on various medical conditions such as cholesterol and hypertension, migraines, skin conditions, smoking cessation, viruses, weight loss, and women's health. With a dedicated team of professionals, HRHR emphasizes patient-centered research, ensuring that participants receive exceptional care throughout the trial process. The organization has successfully contributed to the market by adding new drugs and treatments since its inception, showcasing its commitment to advancing medical science and improving patient care. HRHR operates with a mission to deliver high-quality research while fostering partnerships with sponsors and CROs to accelerate clinical trials.

12. LifeNet Health LifeSciences

• Website: lnhlifesciences.org
• Ownership type: Private
• Headquarters: Virginia Beach, Virginia, United States (USA)
• Employee distribution: United States (USA) 92%, France 8%
• Founded year: 2017
• Headcount: 51-200
• LinkedIn: lifenet-health-lifesciences

LifeNet Health LifeSciences, founded in 2017 and based in Virginia Beach, Virginia, operates as a private research solutions provider in the life sciences sector. The company specializes in delivering human primary cells, biospecimens, and in vitro testing services tailored for pharmaceutical and biotech companies. Their offerings are designed to enhance research and development processes, particularly in drug development and safety assessments. LifeNet Health LifeSciences emphasizes the importance of human-relevant data, which is increasingly sought after in the industry as companies move away from traditional animal models. Their clientele includes prominent names in the pharmaceutical industry, showcasing their role in supporting groundbreaking discoveries and improving health outcomes. The company also engages in partnerships to expand their capabilities and enhance their service offerings, reflecting a commitment to innovation and collaboration in the life sciences field.

13. Dunn Regulatory Associates, LLC

• Website: dunnregulatory.com
• Ownership type: Private
• Headquarters: Oakton, Virginia, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2014
• Headcount: 1-10
• LinkedIn: dunn-regulatory-associates-llc

Dunn Regulatory Associates, LLC, founded in 2014 and based in Oakton, Virginia, is a regulatory consulting firm that specializes in the healthcare industry. The company offers a comprehensive range of services aimed at assisting pharmaceutical and biotech companies in navigating the intricate regulatory landscape. Their expertise spans nonclinical and clinical consulting, Chemistry, Manufacturing, and Controls (CMC), compliance consulting, and medical writing. Dunn Regulatory Associates is known for its strategic approach to regulatory challenges, helping clients streamline product development from discovery to market. They have a team of experienced consultants who provide guidance on regulatory submissions, compliance with FDA and EMA requirements, and the preparation of essential documentation for drug applications. Their clientele includes various pharmaceutical and biotech firms, indicating their active involvement in the industry.

14. Impact Pharmaceutical Services

• Website: impactpharma.com
• Ownership type: Corporate
• Headquarters: Triangle, Virginia, United States (USA)
• Employee distribution: United States (USA) 69%, Egypt 31%
• Latest funding: February 2022
• Founded year: 2009
• Headcount: 11-50
• LinkedIn: impact-pharmaceutical-services

Impact Pharmaceutical Services, now integrated into Syner-G BioPharma Group, is a pharmaceutical consulting firm based in Triangle, Virginia. Founded in 2009, the company specializes in drug development, regulatory strategy, and quality compliance services. They assist pharmaceutical and biotechnology clients in overcoming regulatory hurdles and achieving successful product approvals. Their comprehensive suite of services includes CMC development, regulatory submissions, and quality management systems. With a team of experienced professionals, Impact Pharmaceutical Services has built a reputation for providing tailored solutions that address the unique challenges faced by their clients in the biopharmaceutical sector. Their recent merger with Syner-G BioPharma Group enhances their capabilities, allowing them to offer integrated solutions across the drug development process.

15. Atlantic Research Group

• Website: atlanticresearchgroup.com
• Ownership type: Private
• Headquarters: Charlottesville, Virginia, United States (USA)
• Employee distribution: United States (USA) 87%, United Kingdom (UK) 13%
• Founded year: 2004
• Headcount: 51-200
• LinkedIn: atlantic-research-group

Atlantic Research Group (ARG), founded in 2004 and based in Charlottesville, Virginia, operates as a Contract Research Organization (CRO) that provides a range of clinical research services. With a workforce of approximately 91 employees, ARG focuses on supporting pharmaceutical and biopharmaceutical companies through various stages of clinical trials. Their expertise spans critical therapeutic areas such as oncology, immunology, and neurology. ARG offers services including clinical operations, medical monitoring, data management, and quality assurance, among others. They have successfully managed over 50 market authorizations, showcasing their capability in handling complex clinical trials. Their approach emphasizes collaboration and customization, ensuring that they meet the specific needs of their clients. This adaptability has led to a strong reputation in the industry, with 85% of their business coming from repeat clients. ARG's commitment to regulatory compliance and patient-centric studies further solidifies their role in advancing new therapies.

16. Accell Clinical Research

• Website: accellclinical.com
• Ownership type: Private
• Headquarters: Warrenton, Virginia, United States (USA)
• Employee distribution: Russia 57%, United States (USA) 34%, Canada 9%
• Founded year: 2006
• Headcount: 11-50
• LinkedIn: accell-clinical-research-llc

Accell Clinical Research, founded in 2006 and based in Warrenton, Virginia, is a private clinical research organization that provides comprehensive services for clinical trials. The company supports pharmaceutical and biotechnology clients by managing clinical studies with a strong emphasis on timely patient recruitment and operational efficiency. Accell has carved out a niche in oncology, being recognized for its expertise in this area, and has successfully conducted numerous clinical trials across Europe and the Eurasian Economic Union. Their operational strategy includes a dedicated team of medical professionals and connections to prominent medical institutions, which enhances their ability to deliver results. Accell's commitment to quality is reflected in their history of successful audits and inspections, ensuring that they meet the rigorous standards required in clinical research. They have also been involved in launching new Phase III studies in oncology and ophthalmology, showcasing their ongoing engagement in the industry.

17. PSNResearch

• Website: psnresearch.com
• Ownership type: Private
• Headquarters: Charlottesville, Virginia, United States (USA)
• Employee distribution: Spain 40%, Italy 20%, United States (USA) 20%, Other 20%
• Founded year: 1997
• Headcount: 201-500
• LinkedIn: pharmaceutical-service-network-llc

PSNResearch, founded in 1997 and based in Charlottesville, Virginia, is a private clinical research organization that specializes in comprehensive services for drug development. The company assists pharmaceutical and biotech firms in navigating the intricate landscape of clinical research, ensuring successful outcomes through regulatory compliance and clinical trials management. With a workforce of 201-500 employees, PSNResearch operates across multiple countries, including Spain, Italy, the United States, and France. Their service offerings include regulatory and legal support, medical expertise, biometrics, safety management, and quality assurance. They have a strong focus on advanced therapies, first-in-human clinical trials, and various therapeutic areas such as hematology, oncology, and neurology. PSNResearch's commitment to transparency and client-centered research makes them a significant player in the biopharmaceutical industry.

18. Capra Biosciences

• Website: caprabiosciences.com
• Ownership type: Venture Capital
• Headquarters: Manassas, Virginia, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Convertible note, November 2024
• Founded year: 2020
• Headcount: 1-10
• LinkedIn: capra-biosciences

Capra Biosciences, founded in 2020 and based in Manassas, Virginia, is a biotechnology firm dedicated to sustainable chemical production. The company specializes in utilizing advanced bioreactor technology and biofilm processes to manufacture renewable chemicals, such as retinol, which is widely used in the pharmaceutical and cosmetic industries. Capra's innovative approach transforms waste into valuable materials, aligning with the growing demand for environmentally friendly manufacturing solutions. Recently, they secured a $7.5 million project agreement to demonstrate their platform for rapidly scaling the production of bio-derived small-molecule active pharmaceutical ingredients (APIs). This initiative aims to enhance domestic pharmaceutical manufacturing capabilities and address ingredient shortages, showcasing Capra's commitment to improving the biopharmaceutical supply chain.

19. LumaCyte

• Website: lumacyte.com
• Ownership type: Corporate
• Headquarters: Charlottesville, Virginia, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Series B, September 2023
• Founded year: 2012
• Headcount: 11-50
• LinkedIn: lumacyte

LumaCyte, Inc. is a biotechnology firm based in Charlottesville, Virginia, founded in 2012. The company focuses on advanced research and bioanalytics instrumentation, offering innovative solutions for label-free single cell analysis. Their flagship product, the Radiance® platform, utilizes Laser Force Cytology™ to provide real-time insights into cellular behavior without the need for antibody or genetic labeling. This technology is particularly valuable in the biopharmaceutical sector, where it supports applications such as vaccine development, gene therapy, and cell therapy. By enabling scientists to monitor critical quality attributes and optimize bioprocesses, LumaCyte plays a significant role in enhancing the efficiency and effectiveness of biotherapeutic manufacturing. The company operates with a small team, emphasizing a specialized approach to bioanalytics.

20. Glen Research

• Website: glenresearch.com
• Ownership type: Corporate
• Headquarters: Sterling, Virginia, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: January 2018
• Founded year: 1986
• Headcount: 11-50
• LinkedIn: glen-research

Glen Research, founded in 1986 and based in Sterling, Virginia, is a biotechnology company that specializes in providing supplies for oligonucleotide synthesis. The company offers a comprehensive range of products, including DNA and RNA nucleosides, phosphoramidites, and purification reagents. These products are primarily aimed at businesses and organizations within the biotechnology and pharmaceutical sectors, supporting their research and development efforts. Glen Research is part of Maravai LifeSciences, which enhances its credibility and reach within the industry. The company has built a reputation for delivering high-quality reagents that are crucial for nucleic acid synthesis, making it a significant contributor to advancements in genetic research and therapeutic development.

21. Ascend Therapeutics

• Website: ascendtherapeutics.com
• Ownership type: Private
• Headquarters: Herndon, Virginia, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2001
• Headcount: 11-50
• LinkedIn: ascend-therapeutics

Ascend Therapeutics is a private pharmaceutical company based in Herndon, Virginia, established in 2001. The company specializes in hormone therapies aimed at improving hormonal health for both men and women. Their product portfolio includes EstroGel, which is designed to alleviate menopausal symptoms, and AndroGel, a treatment for testosterone deficiency in men. With a focus on innovative solutions, Ascend Therapeutics aims to enhance access to effective treatments for hormonal imbalances. The company operates under the umbrella of Besins Healthcare, a global entity recognized for its expertise in hormonal therapies, which adds to Ascend's credibility in the market. Their commitment to advancing the science of hormonal balance reflects a mission-driven approach to healthcare, targeting significant health challenges faced by many individuals.

22. Revivicor, Inc.

• Website: revivicor.com
• Ownership type: Corporate
• Headquarters: Blacksburg, Virginia, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: $7.6M, July 2011
• Founded year: 2003
• Headcount: 1-10
• LinkedIn: revivicor-inc.

Revivicor, Inc., based in Blacksburg, Virginia, is a biotechnology firm founded in 2003. The company specializes in xenotransplantation, aiming to provide genetically engineered organs from pigs to alleviate the critical shortage of human organs available for transplant. Revivicor utilizes advanced gene editing technologies to enhance the compatibility of these organs, targeting healthcare providers and patients in need of transplants. Their notable products include the UHeart™ and UKidney™, which are currently in development and have been involved in significant clinical trials. Revivicor is a subsidiary of United Therapeutics Corporation, which further supports its mission to innovate in the field of organ transplantation. The company has received funding, with a notable amount of $7.6 million reported in 2011, indicating ongoing interest in their research and development efforts.

23. Afton Scientific, LLC

• Website: aftonscientific.com
• Ownership type: Private Equity
• Headquarters: Charlottesville, Virginia, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: January 2024
• Founded year: 1991
• Headcount: 51-200
• LinkedIn: afton-scientific-llc

Afton Scientific, LLC, based in Charlottesville, Virginia, is a pharmaceutical contract development and manufacturing organization (CDMO) that has been operational since 1991. The company specializes in the sterile filling of small-volume injectable drugs, catering to both commercial and clinical trial needs. Afton Scientific offers a range of services, including contract manufacturing, cGMP lab services, and the provision of custom components. Their facilities are designed to meet stringent regulatory standards, ensuring that all products are compliant with cGMP requirements. Afton’s expertise extends to filling various formulations, including mRNA and monoclonal antibodies, which are increasingly important in today's biopharmaceutical landscape. The company prides itself on its commitment to quality and timely delivery, making it a reliable partner for pharmaceutical companies.

24. Epl

• Website: epl-inc.com
• Ownership type: Corporate
• Headquarters: Sterling, Virginia, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: November 2020
• Founded year: 1971
• Headcount: 51-200
• LinkedIn: epl_2

Experimental Pathology Laboratories, Inc. (EPL) is a private, employee-owned company based in Sterling, Virginia, with a history dating back to 1971. The firm specializes in histology, toxicology, and pathology services tailored for pharmaceutical research and development. EPL is recognized for its commitment to high-quality service and timely delivery, providing expert evaluations and consultations that help pharmaceutical companies and research organizations navigate the complexities of preclinical studies. With a team of over 100 trained professionals, including board-certified pathologists and histotechnologists, EPL offers a range of services that include toxicologic pathology evaluations, histology processing, and consulting. Their expertise is particularly valuable in ensuring compliance with regulatory standards and enhancing the quality of research outcomes. EPL operates two fully-equipped laboratories capable of processing a significant volume of tissue specimens annually, underscoring their capacity to support extensive research projects. Their role in the industry is pivotal, as they contribute to the safety and efficacy assessments that are essential for the development of new drugs.

Biopharmaceutical Companies Insights: Key Companies in Virginia

Want to Find More Biopharmaceutical Companies Companies?

With Inven you'll also get to know the company's:

• Detailed Ownership: Who owns the company? Is it a public or private company? What is the ownership structure?
• Contact data: Who are the founders and CEO's? What are their emails and phone numbers?
• Financials: How do these companies perform financially? What are their revenues and profit margins?

...and a lot more!